Esperion Therapeutics (NASDAQ:ESPR) Cut to Hold at StockNews.com
StockNews.com cut shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) from a buy rating to a hold rating in a research note released on Friday morning. Several other research firms have also weighed in on ESPR. Needham & Company LLC lowered their price objective on Esperion Therapeutics from $8.00 to $6.00 and set a buy […]
More Stories
Sernova (OTCMKTS:SEOVF) Releases Earnings Results
Sernova (OTCMKTS:SEOVF – Get Free Report) posted its earnings results on Monday. The company reported ($0.01) EPS for the quarter,...
GoviEx Uranium (CVE:GXU) Stock Price Down 18.2% – What’s Next?
Shares of GoviEx Uranium Inc. (CVE:GXU – Get Free Report) traded down 18.2% during mid-day trading on Monday . The...
Nordstrom to Go Private in $6.25 Billion Deal
By Austin Alonzo American luxury department store chain Nordstrom will be taken private in a $6.25 billion deal, according to...
Former President Bill Clinton Hospitalized With Fever, Spokesperson Says
By Jack Phillips Former President Bill Clinton was checked into a Washington hospital on Monday after developing a fever, said...
Cosmos Health (NASDAQ:COSM) vs. Aceto (OTCMKTS:ACETQ) Head to Head Analysis
Aceto (OTCMKTS:ACETQ – Get Free Report) and Cosmos Health (NASDAQ:COSM – Get Free Report) are both small-cap medical companies, but...
Invesco Dorsey Wright Utilities Momentum ETF (NASDAQ:PUI) Plans Dividend of $0.20
Invesco Dorsey Wright Utilities Momentum ETF (NASDAQ:PUI – Get Free Report) announced a dividend on Monday, December 23rd,NASDAQ Dividends reports....